Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancer.

Jie ZhengYubo WangChen HuMengxiao ZhuJianghua IiCaiyu LinConghua LuYuanyao DouChenlong ZhaoYimin ZhangDi WuLi LiHuan TangTingting HeChunxiao PanRui HanYong He

Published in: Thoracic cancer (2022)

We based this study on ctDNA and cfDNA, explored its prognostic predictive ability, and combined CEA to monitor EGFR-TKI efficacy. This study may provide new perspectives and insights into the precise treatment strategies for NSCLC patients.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
small cell lung cancer
end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
combination therapy
replacement therapy
patient reported
circulating tumor cells